Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Meeting Results June 6, 2012

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Omontys New Drug Initial Review Require Prior Approval Prior Approval Required
Pulmicort Flexhaler New Drug Initial Review Require Prior Approval Prior Approval Requirement
Tradjenta New Drug Appeal Require Prior Approval Prior Approval Required
Effient New Drug Appeal Require Prior Approval Prior Approval Required
Zemplar New Drug Appeal Require Prior Approval Prior Approval Required
Daliresp New Drug Appeal Require Prior Approval Prior Approval Required
Xarelto PDL Appeal Remove Prior Approval Requirement Preferred and Require Prior Approval
Vesicare PDL Appeal Require Prior Approval Prior Approval Required